Patients with type 2 diabetes treated with sodium-glucose cotransporter-2 (SGLT-2) inhibitors have a significantly lower risk of developing dementia and Alzheimer's disease than those receiving ...
SaveHealth reports on managing type 2 diabetes through medications, lifestyle changes, and support, highlighting various ...
In September, Indian drug manufacturer Alembic received a tentative nod from the US Food and Drug Administration (FDA) to manufacture generic alogliptin as well as the alogliptin/metformin fixed-drug ...
In a recent large-scale retrospective cohort study published in the journal Primary Care Diabetes, researchers used a comprehensive (n = 10,465) database-derived dataset to evaluate the adherence and ...
Merck announced that expanded labeling has been approved for Januvia (sitagliptin), the only DPP-4 inhibitor indicated domestically as an adjunct to diet and exercise to improve glycemic control in ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Most adults with type 2 diabetes receiving an ...
Verywell Health on MSN
The best time to take blood sugar medication based on the type you use
Medically reviewed by Kristie Reed, PharmD The best time of day to take medication for diabetes varies, depending on the type of medication. Some medications should be taken with food to lessen the ...
Please provide your email address to receive an email when new articles are posted on . Adults with type 2 diabetes who began GLP-1 therapy were less likely to develop hyperkalemia than adults ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback